top of page
Read • watch • learn
Welcome to the Hope Bio Blog
Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for COVID-19
By the Hope Biosciences Editorial Team HOUSTON, TX, April 13, 2020 - Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has approved a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences’ allogeneic, adipose-derived mesenchymal stem cells (HB-adMSCs) to provide immune support against COVID-19. During this pandemic, there are currently no appro
Hope Biosciences
Apr 13, 20202 min read
FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19
By the Hope Biosciences Editorial Team HOUSTON, TX, April 06, 2020 – Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) to provide immune support against COVID-19. MSCs are well-known for their immunomodulatory and reg
Hope Biosciences
Apr 6, 20203 min read
bottom of page